Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879879 · ClinicalTrials.gov registry record · NA
Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00879879 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 20 participants.
The verdict
NCT00879879, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
RATIONALE: Losartan may be effective in treating patients with idiopathic pulmonary fibrosis. PURPOSE: This clinical trial is studying the side effects of losartan and to see how well it works in treating patients with idiopathic pulmonary fibrosis.
Interventions
- DRUG losartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00879879
The ClinicalTrials.gov registry entry for NCT00879879 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which losartan is the first listed.
NCT00879879 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00879879 about?
NCT00879879 is a clinical study titled "Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis". RATIONALE: Losartan may be effective in treating patients with idiopathic pulmonary fibrosis. PURPOSE: This clinical trial is studying the side effects of losartan and to see how well it works in treating patients with idiopathic pulmonary fibrosis.
What is the current status of trial NCT00879879?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-03. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00879879?
The interventions under investigation include: losartan (DRUG).
Who is sponsoring clinical trial NCT00879879?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.